MedPath

Exploring Emotional Intelligence and Cognitive Flexibility in Anorexia Nervosa and Parkinson's Disease.

Recruiting
Conditions
Anorexia Nervosa
Parkinson Disease
Registration Number
NCT06323564
Lead Sponsor
Istituto Auxologico Italiano
Brief Summary

The main aim of this study is to demonstrate how disorders characterized by different types of "inflexibility", cognitive-affective type for Anorexia nervosa and motor one for Parkinson's disease, have an impact on how emotional stimuli are processed and on the transition within emotional states.

Detailed Description

Although many psychometric models have been developed on emotions, affect measurements, which represent the measurement of behavioural, subjective and neuropsychophysiological changes associated with an emotional episode, still remains one of the most debated topics. Emotions are entities with blurred boundaries and with substantial idiosyncrasies that characterize their measurable manifestations. One of the most consolidated theoretical reference models for measuring affect is that of James Russel called the "Affective Core Model". According to this model, emotion arises when the undifferentiated and pre-reflective magma of affect (core affect) is attracted by an external (or internal) object that can be defined as emotigenic, i.e. capable of defining the nature of emotional experience by orienting it along two dimensions principal factors. The most used theoretical model for affect measurement is the one that describes an emotional episode in the light of two distinguishable continuous dimensions: that of hedonic value (identifies the degree of pleasantness of the emotional event), of a subjective nature, and that of arousal or psychophysiological activation. Although this model has been widely corroborated in various disciplines, there is still a lack of a clear description of the process that allows an individual to transition from one emotionally object-oriented state to another.

This project proposes and intends to validate a new modality of three-dimensional psychometric modeling of emotions, based on the intersection between the consolidated two-dimensional model of arousal-valence and a third purely cognitive component definable as mental flexibility, capable of including high-level cognitive processes, intrinsically connected with the emotional sphere, such as emotional intelligence (Emotional Intelligence, EI) and emotional regulation.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Parkinson's Disease
  • Anorexia nervosa
  • Written informed consent
Exclusion Criteria
  • Other psychiatric disorders
  • Acute infectious diseases
  • Chronic inflammatory diseases
  • Other Disorders of central nervous system
  • Pregnancy or breastfeeding
  • tachy or bradyarrhythmias, other cardiac rhythm alterations that compromise the study of heart rate variability

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in International Affective Picture System (IAPS)At baseline T0 (hospital admission) and T1 (15 days after T0 for PD, 4 weeks after T0 for AN)

Self-Assessment Manikin (SAM) scale. Range score for each image: 1-5 (IAPS test: 24 blocks of 2 minutes and for each block there will be 12 images of 10 seconds each).

Secondary Outcome Measures
NameTimeMethod
Change in Heart rate variabilityAt baseline T0 (hospital admission) and T1 (15 days after T0 for PD, 4 weeks after T0 for AN)

High frequency (range 0.15-0.40 hz)

* Low frequency (range 00.4-0.15 hz)

* Ratio Low frequency/High frequency

Change in self-report questionnaires - STAIAt baseline T0 (hospital admission) and T1 (15 days after T0 for PD, 4 weeks after T0 for AN)

State-Trait Anxiety Inventory (STAI); score range 20-80

Change in analysis of bio-humoral parametersAt baseline T0 (hospital admission), after 2 weeks and T1 (4 weeks after T0 for AN)

Serotonin in serum (range 30 - 200 ng/ml)

Change in self-report questionnaires - BDIAt baseline T0 (hospital admission) and T1 (15 days after T0 for PD, 4 weeks after T0 for AN)

Beck's Depression Inventory (BDI); score range 0-63

Trial Locations

Locations (1)

Istituto Auxologico Italiano

🇮🇹

Oggebbio, Italy

Istituto Auxologico Italiano
🇮🇹Oggebbio, Italy
Riccardo Cremascoli, MD, PhD
Contact
© Copyright 2025. All Rights Reserved by MedPath